Eighteen Owners, One Company: How a $1.6 Billion Rehab Network Stayed Invisible for Six Years

The therapy was a phone. According to the charging documents unsealed in Los Angeles on Oct. 22, a single cell phone was muted, its camera switched off, and set face-down on a kitchen island while patients in a residential addiction treatment program went about their day. The Zoom session stayed logged in. The minutes were billed as group therapy.

One patient, prosecutors say, never attended a single therapy session across 13 months in one of the programs. Other line items billed under the same code included go-karting, movie tickets, dinners and trips to the beach.

That detail is grotesque, but it is not the most important thing in the case. The most important thing is the corporate architecture that let it run for six years.

What the Indictment Alleges the Money Bought

Federal prosecutors in the Central District of California charged David and Nathan Young, a father and son who owned and operated more than 20 addiction treatment facilities across Southern California, with what the office described as the largest substance abuse treatment fraud scheme in the history of federal prosecution.

Between May 2020 and May 2026, the government alleges the network submitted $1,619,276,243 in false claims to commercial insurers and collected more than $210 million in payments. The rehab scheme was the bulk of a broader takedown announced the same morning that reached roughly $2 billion in alleged losses and produced charges against 15 defendants, at least eight of whom were arrested. Six were doctors. One surgeon and a chiropractor business partner were separately accused of running unnecessary artery procedures and inventing follow-up operations when the first one "failed," extracting about $134 million.

The Youngs face eight counts of health care fraud, six counts of illegal kickback violations tied to the Eliminating Kickbacks in Recovery Act, three further counts of health care fraud, and single counts of conspiracy to commit health care fraud and wire fraud and to violate EKRA. Neither has entered a plea. No trial date has been set.

Eighteen Owners and One Address

Here is the mechanism the case turns on, and it is a more interesting claim than the bribes.

The scheme allegedly worked because the Youngs did not appear to own anything. Of the roughly 20 California locations involved, 18 were nominally held by different owners attached to shell companies. To an insurer processing a claim, each facility looked like an independent operator with its own tax identification number, its own billing history and its own clinical leadership. To anyone looking at all of them together, the claims were flowing out of one centralized entity.

That is a fraud-control problem dressed as a paperwork problem. Insurance fraud units and law enforcement investigators work claim by claim and provider by provider. A blue-pencil review of a single small treatment center in Sacramento would find a plausible-looking organization with plausible-looking documentation. It takes a deliberate cross-entity query — same billing patterns, same referral sources, same beneficiary addresses, same medical director of record — to see the network. The indictment's implication is that nobody ran that query for four years, and that approximately $210 million in actual payments moved in the meantime.

The Department of Justice has been circling this sector. In June, it filed charges in 39 behavioral health billing fraud cases, and addiction treatment providers accounted for 68.7 percent of the total suspected fraud across them. A takedown of this size — with the phrase "largest in U.S. prosecution history" attached — tends to be followed by pattern-driven enforcement rather than one-off prosecutions, which means the shell-company structure described in this indictment is now a thing investigators will be looking for specifically.

EKRA Was Written for Exactly This

The charge that matters legally is the kickback count, because it explains why a case built on commercial insurance is a federal case at all.

Why the Anti-Kickback Statute Could Not Reach It

The federal Anti-Kickback Statute is tied to items and services paid for by federal health care programs. A patient broker paid to steer a commercially insured patient into a private-pay-or-insurance detox does not, by itself, implicate Medicare or Medicaid — which is why "body brokering" flourished for years in states with large insured populations and permissive licensing.

Congress closed that gap on Oct. 24, 2018, when it folded the Eliminating Kickbacks in Recovery Act into the SUPPORT for Patients and Communities Act. Section 1822 of that law, codified at 18 U.S.C. § 220, makes it a crime to solicit or receive — or to pay or offer — any remuneration, "directly or indirectly, overtly or covertly, in cash or in kind," in return for referring a patient to a recovery home, a clinical treatment facility, or a laboratory, with respect to services covered by any health care benefit program. Not a federal one. Any of them.

The statute defines a clinical treatment facility as a medical setting other than a hospital that provides detoxification, risk reduction, outpatient treatment, residential treatment or rehabilitation for substance use under state licensure. A recovery home is defined as a shared living environment that purports to be free of alcohol and illicit drug use and centered on peer support. Both definitions were drafted with this industry in mind.

Six EKRA counts against two defendants, in a case where the recruiting inducements allegedly included flights, hotel rooms, cash, cars, cigarettes, marijuana and access to illegal drugs, is about as direct an application of the statute as the docket is likely to produce.

The Patients Were the Inventory

The recruitment allegations are the part that should concern anyone who has ever helped a family member find a bed.

Body brokers, prosecutors say, were instructed to look for people with commercial insurance policies that paid well — unhoused people, impoverished people, people already navigating addiction. One account in the Los Angeles Times reporting describes brokers paid to recruit homeless residents out of state, including from Texas, and people in 12-step programs, who were then signed up for expensive insurance policies on arrival and housed in squalid conditions. Patients told investigators about cramped "trap house" arrangements. Some had their belongings withheld. Some were physically blocked from leaving.

The clinical allegations are worse than neglect. Some patients, according to the charging documents, were asked to fabricate symptoms in order to qualify for detoxification services the facilities could bill. Others, prosecutors say, were encouraged to use substances for the same reason: a positive toxicology screen converts an empty bed into a billable episode. In one message quoted in the filings, dated Jan. 20, 2023, Nathan Young is said to have responded to a report that a "premium patient" wanted to leave detox to smoke marijuana by directing that the patient be given edibles off-site, and that whoever supplied them should not be affiliated with the detox.

A treatment center that needs a patient to be intoxicated in order to get paid has inverted its own purpose. That is not a compliance failure at the margins of legitimate care. It is a business model.

A Takedown Announced Twice

The politics arrived within the hour.

First Assistant U.S. Attorney Bill Essayli opened a 9:30 a.m. news conference in downtown Los Angeles by declaring that "California has a fraud problem," and has made a practice of calling Gov. Gavin Newsom the "king of fraud." California Attorney General Rob Bonta held his own conference across the street an hour later and accused federal prosecutors of deliberately erasing his office's contribution — including the arrest of the Anaheim surgeon — describing the pattern as "improper politicization and weaponization" of medical fraud investigations. "This isn't a political game for us," Bonta said. Essayli's reply: "Getting fraudsters after they've stolen hundreds of millions of dollars is not good enough. The fraud should never have happened in the first place."

Both men are describing the same failure from opposite ends. Bonta is right that a prosecution is a poor substitute for a licensing regime that would have caught a network of 18 shell-owned facilities before it billed its first $200 million. Essayli is right that the detection came late. What neither press conference addressed is the specific mechanism — cross-entity claims analysis — that would have closed the gap, and which no state addiction-treatment licensing authority currently performs at the scale this scheme required.

What This Means for Families Choosing a Program

The practical lesson is not that residential treatment is dangerous. It is that ownership opacity is a warning sign, and that it is checkable before a bed is booked.

A legitimate program will tell you who owns it and who the clinical director is, and the same name will show up in state licensing records. It will not offer to fly your family member across the country for free. It will not hand out cash, cigarettes or spending money at intake. It will not describe its therapy as "experiential" without telling you what the licensed clinicians do all day. Detoxification, residential care and outpatient programming are distinct levels of care with different staffing requirements and different evidence behind them; a facility that cannot explain which level it is providing, and who is providing it, is telling you something.

Families can also ask a question that would have broken this scheme open: how many programs does this company operate, and under how many names? A single owner with 20 locations and 18 different corporate identities is a structural fact, not a private one.

The Limits of a Billing Case

Two things this indictment does not establish, and both matter.

First, the dollar figure is a billed amount, not a loss. Of the $1.6 billion in alleged false claims, about $210 million was actually paid — insurers denied or clawed back the rest, which is the usual shape of health care fraud statistics and the reason headline numbers in this genre should be read as exposure rather than theft.

Second, an indictment is an allegation. No plea has been entered, no trial date set, and 15 defendants in a multi-scheme takedown is a long way from 15 convictions. The patient accounts quoted in the filings come from cooperating witnesses and people with their own incentives, and the government's case will be tested against them.

What survives both caveats is the structural claim, and it is the one the industry should be thinking about. The scheme was not hidden in a basement. It was distributed across 20 licensed addresses, each of which looked unremarkable on its own. For anyone with opioid use disorder or any other substance use disorder trying to find real care, the defense against this is not vigilance about one facility. It is the habit of asking who is behind all of them.